Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GlaxoSmithKline inks a back-loaded $100M deal with Idera for renal R&D
GlaxoSmithKline inks a back-loaded $100M deal with Idera for renal R&D
GlaxoSmithKline inks a back-loaded $100M deal with Idera for renal R&D
Submitted by
admin
on November 24, 2015 - 9:45am
Source:
Fierce Biotech
News Tags:
GSK
Idera Pharmaceuticals
renal disease
R&D
Headline:
GlaxoSmithKline inks a back-loaded $100M deal with Idera for renal R&D
Do Not Allow Advertisers to Use My Personal information
